One year ago I wrote a piece called “Change” about the promise of vaccine clinical trials and summer reopenings, versus the possibility of summer (2020) COVID surges. The article ended: “What we don’t know is, will May of 2020 be part of the beginning, the middle, or the end?”

A few months ago the talk was about which vaccines were in clinical trials, which were approved for emergency use, and when they would be available. Next we worried about who was eligible and how to get our shots. Now, five months into the vaccination rollout, we have had enough time and experience to move forward in the areas of efficacy, improvements, and accessibility.